These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7587072)

  • 1. p21 is a component of active cell cycle kinases.
    Zhang H; Hannon GJ; Casso D; Beach D
    Cold Spring Harb Symp Quant Biol; 1994; 59():21-9. PubMed ID: 7587072
    [No Abstract]   [Full Text] [Related]  

  • 2. p21: structure and functions associated with cyclin-CDK binding.
    Ball KL
    Prog Cell Cycle Res; 1997; 3():125-34. PubMed ID: 9552411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21/p53, cellular growth control and genomic integrity.
    el-Deiry WS
    Curr Top Microbiol Immunol; 1998; 227():121-37. PubMed ID: 9479828
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
    Grzelakowska-Sztabert B
    Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
    [No Abstract]   [Full Text] [Related]  

  • 6. Under arrest at atomic resolution.
    Morgan DO
    Nature; 1996 Jul; 382(6589):295-6. PubMed ID: 8684452
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.
    Ekholm SV; Reed SI
    Curr Opin Cell Biol; 2000 Dec; 12(6):676-84. PubMed ID: 11063931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
    Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
    Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases.
    De Luca A; Santra M; Baldi A; Giordano A; Iozzo RV
    J Biol Chem; 1996 Aug; 271(31):18961-5. PubMed ID: 8702560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
    Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constraining the cell cycle: regulating cell division and differentiation by gene therapy.
    Stinchcomb DT
    Nat Med; 1995 Oct; 1(10):1004-6. PubMed ID: 7489353
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
    Wu H; Wade M; Krall L; Grisham J; Xiong Y; Van Dyke T
    Genes Dev; 1996 Feb; 10(3):245-60. PubMed ID: 8595876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-induced p21 controls DNA replication.
    Waga S; Li R; Stillman B
    Leukemia; 1997 Apr; 11 Suppl 3():321-3. PubMed ID: 9209378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
    Boulaire J; Fotedar A; Fotedar R
    Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21Wafl/Cipl and p53 expression in the skin - intertwined but not inseparable.
    Quinn AG
    Br J Dermatol; 1999 Oct; 141(4):614-6. PubMed ID: 10583106
    [No Abstract]   [Full Text] [Related]  

  • 19. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclins, Cdks, and cyclin kinase inhibitors.
    Roberts JM; Koff A; Polyak K; Firpo E; Collins S; Ohtsubo M; Massagué J
    Cold Spring Harb Symp Quant Biol; 1994; 59():31-8. PubMed ID: 7587083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.